Disability and Health Care Interactions in Patients with Celiac Disease in the United States: An Analysis of All of Us Cohort.

Patient mental state deterioration (MSD) in acute hospital settings includes a decline in cognitive, emotional, and psychological well‐being, leading to poor patient outcomes and challenges for healthcare providers (ACSQH ; Lamont et al. ). Symptoms such as sudden mental state changes, reduced attention, mood instability, and altered perceptions of reality often stem from medical complications, adverse drug reactions, metabolic imbalances, pain, pre‐existing psychiatric conditions, substance misuse, and environmental factors (Bak et al. ; Roppolo et al. ). Experiencing MSD in hospital can be distressing for both patients and their families. The unfamiliar and often overstimulating hospital environment may heighten feelings of confusion, fear, and isolation, particularly when patients are unable to clearly communicate their needs or understand what is happening around them (Nia Manning ). Such experiences can lead to emotional disconnection, mistrust, and increased mental distress (Nitchingham and Caplan ). Families may feel distressed, powerless, and uncertain about how to support their loved ones during episodes of MSD, especially when communication with healthcare teams may be unclear or inconsistent (Craze et al. ). Recognising and responding to MSD with trauma‐informed, patient‐centred care is crucial not only to reduce the distress experienced by patients but also to reassure families and support their role in care continuity (ACSQH ; ACSQHC ). Acknowledging the lived experience of MSD for patients and families through structured, inclusive practices can improve both clinical outcomes and the care experience (ACSQHC , ; Garrubba and Joseph ). MSD impacts decision‐making and care quality, often leading to the use of restrictive practices, prolonged hospital stays, and increased reliance on psychotropic medications (Morphet et al. ; Tomlinson et al. ). Psychopharmacological treatments carry risks, including cardiovascular, extrapyramidal, and metabolic complications, particularly in elderly patients who are more susceptible to delirium, cognitive decline, falls, and functional deterioration because of polypharmacy (Abraham et al. ; Egberts et al. ).